Prevalence and risk factors of HBsAg in Gaza: Implications for prevention and control

Journal of Infection

Volumn 44, Issue 4, 2002, Pages 252-256

  Yassin, Khaled ^a   Awad, Riyad ^b   Tebi, Abd Jabbar ^c   Queder, Ali ^c   Laaser, Ulrich ^a  

^a BIELEFELD UNIVERSITY   (Germany)

^b Penn State Berks   (United States)

^c Palestinian National Authority   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ACUTE HEPATITIS; ARAB; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE TRANSMISSION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION PREVENTION; POPULATION RESEARCH; PREVALENCE; RANDOMIZATION; RISK FACTOR; SCREENING TEST; SIMULATION; VACCINATION;

EID: 0036590290     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1053/jinf.2001.0998     Document Type: Article

References (14)

1. Kane MA, Clements J, Hu D. Hepatitis B. In: Jamison DT, Mosley WH, Measham AR, Bobadilla J (eds) Disease Control Priorities in Developing Countries. New York: Oxford University Press, 1993: pp. 321-330.
2. WHO. Hepatitis B. Fact Sheet WHO/204, Revised October 2000, World Health Organization, Geneva, 2000.
3. Yassin K. Unraveling the mystery of liver disease in Egypt: the burden of disease. Verlag Hans Jacobs, Lage, Germany, 2001.
4. Attia MA. Prevalence of hepatitis B and C in Egypt and Africa. Antivir Ther 1998; 3(Suppl 3): 1-9.
5. Sherif MM, Abou-Aita BA, Abou-Elew MH, el-Kafrawi AO. Hepatitis B virus infection in upper and lower Egypt. J Med Virol 1985; 15(2): 129-135.
6. Almog R, Low M, Cohen D, Robin G et al. Prevalence of anti-hepatitis A antibodies, hepatitis B viral markers, and anti-hepatitis C antibodies among immigrants from the former USSR who arrived in Israel during 1990-1991. Infection 1999; 27(3): 212-217.
7. Srugo I, Shinar E, Bar-Shany S, Amos L. Hepatitis B and C markers among alcoholics in Israel: high incidence of HCV infection. Eur J Epidemiol 1998; 14(4): 333-337.
8. Bisharat N, Elias M, Raz R, Flatau E. Familial pattern of infection with hepatitis B virus among immigrating Ethiopian Jews in Israel. Eur J Epidemiol 1998; 14(1): 89-91.
9. Glikberg F, Brawer-Ostrovsky J, Ackerman Z. Very high prevalence of hepatitis B and C in Bukharian Jewish immigrants to Israel. J Clin Gastroenterol 1997; 24(1): 30-33.
10. Weiss Y, Rabinovitch M, Cahaner Y, Noy D, Siegman-Igra Y. Prevalence of hepatitis B virus markers among hospital personnel in Israel: correlation with some risk factors. J Hosp Infect 1994; 26(3): 211-218.
11. Dan M, Rock M, Lilos P, Shany SB. Seroepidemiology of hepatitis B and D virus infection among intravenous drug addicts in Israel. Int J Epidemiol 1993; 22(1): 140-143.
12. Hornstein L, Ben-Porath E, Cuzin A, Baharir Z, Rimon N, Nahmias J. Hepatitis B virus infection in Ethiopian immigrants to Israel. Isr J Med Sci 1991; 27(5): 268-272.
13. Sarov B, Naggan L, Bar-Shany S, Greene VW, Bearman JE. Prevalence of hepatitis B surface antigen and its antibody among medical and nonmedical students at Ben-Gurion University of the Negev, Israel. Isr J Med Sci 1986; 22(12): 921-922.
14. Toukan AU. Hepatitis B in the Middle East: aspects of epidemiology and liver disease after infection. Gut 1996; 38(Suppl 2): S2-S4.